Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality affecting ≈84 million people in the United States.[@b1]--[@b3] Current guidelines recommend exercise for both primary and secondary prevention of CVD.[@b4]--[@b6] Observational studies have associated exercise with lower CVD risk in populations free of preexisting CVD.[@b7]--[@b9] Substantial evidence from secondary prevention studies also confirms better survival and reduced CVD recurrence after exercise interventions.[@b10],[@b11] Because of apparent ethical and feasibility issues, however, no long-term randomized controlled trials (RCTs) have directly investigated the benefits and risks of exercise training in relation to CVD incidence.[@b12] Consequently, exercise interventions among healthy populations have focused on intermediate CVD biomarkers. Changes in circulating CVD biomarkers and cardiorespiratory fitness (CRF) are reasonable indicators for the favorable effects of exercise training on cardiovascular health.

An important component of health-related fitness, CRF refers to the capacity of respiratory and cardiovascular systems to provide muscles with oxygen during sustained and/or intense exercise. Available evidence has shown that CRF can significantly improve the predictive ability of both short- and long-term CVD risk when added to traditional risk factors.[@b13] In addition to serving as a diagnostic and prognostic health indicator in clinical settings, CRF has been used as an indicator of habitual exercise.[@b14],[@b15]

Traditional CVD biomarkers, such as non--high-density lipoprotein cholesterol and high-sensitivity C-reactive protein, may also have the potential to be used in CVD risk prediction.[@b16]--[@b19] Although most previous studies examining the relationship between exercise and circulating biomarkers focus on commonly measured CVD biomarkers, an increasing number of studies are evaluating novel biomarkers.[@b20],[@b21] Evidence has implicated, for example, relevant biomarkers in insulin resistance and inflammation that contribute to CVD development.[@b22]--[@b26]

Nevertheless, much remains uncertain concerning the effects of exercise on both traditional and novel CVD biomarkers for targeted interventions and clinical evaluations.[@b20],[@b21],[@b27] The primary objective of this meta-analysis was to assess the effects of exercise training on CRF and a variety of both traditional and novel circulating CVD biomarkers. Furthermore, we aimed to investigate the sources of heterogeneity, especially by potential effect modifiers such as age, sex, obesity, lifestyle, preexisting conditions (type 2 diabetes, hypertension, hyperlipidemia, or metabolic syndrome), and intervention duration and intensity.

Methods
=======

Data Sources and Searches
-------------------------

We developed and followed a standardized protocol to do this meta-analysis in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.[@b28] Two investigators (X.L., X.Z.) independently conducted literature searches of Medline, Embase, and the Cochrane Central Register of Controlled Trials published from January 1965 (index date) to March 2014, using keywords and Medical Subject Headings (Table[1](#tbl1){ref-type="table"}). All relevant studies and review articles (including meta-analysis) and the reference lists of the identified articles were checked manually. Any disagreements between 2 investigators were resolved by consensus. Institutional review board approval is not applicable because the current study is a systematic review and meta-analysis, which is not considered research involving human subjects.

###### 

Search Strategy for Medline

  ------ ---------------------------------
  1\.    exp Exercise/
  2\.    physical activity.ab.
  3\.    aerobic^\*^.ab.
  4\.    or/1 to 3
  5\.    exp Biological Markers/
  6\.    Exercise Tolerance/
  7\.    Exercise Test/
  8\.    exp Oxygen Consumption/
  9\.    Physical Fitness/
  10\.   or/5 to 9
  11\.   randomized controlled trial.pt.
  12\.   controlled clinical trial.pt.
  13\.   Randomized Controlled Trials/
  14\.   Random Allocation/
  15\.   Intervention Studies/
  16\.   or/11 to 15
  17\.   4 and 10
  18\.   17 and 16
  19\.   limit 18 to English language
  20\.   limit 19 to humans
  ------ ---------------------------------

Study Selection
---------------

Articles were included (1) if the study was an RCT that assigned at least 1 group of participants to exercise training and 1 group to control and (2) if CRF (absolute and relative maximal oxygen uptake) or circulating CVD biomarkers of lipid and lipoprotein metabolism, glucose intolerance and insulin resistance, systemic inflammation, or hemostasis were measured at baseline and at the end of the trial.

All abstracts about RCTs reporting the effect of exercise training on CVD-related biomarkers or CRF were included for screening. We excluded studies (1) if the study design was not a RCT; (2) if the exercise intervention was acute (≤1 week), because we are interested in the effects of exercise interventions of moderate to long duration; (3) if interventions were based on education or counseling rather than a structured exercise training assignment; (4) if maximal oxygen consumption, or VO~2max~, was indirectly calculated through heart rate or fixed time testing and no other biomarkers of interest to this study were reported; (5) if levels of circulating biomarkers were not directly measured; (6) if values of outcome measures at the end of trials were not reported; (7) if participants had severe chronic diseases (preexisting CVD, liver or kidney diseases, or cancers), any other conditions that could potentially compromise participants' capacity to exercise (disability, frailty, declined activities of daily living, or wheelchair dependency), or any mental conditions (depression, anxiety, schizophrenia, bipolar disorder, Parkinson's disease, or Alzheimer's disease); (8) if participants were identified as trained professionals, athletes, or soldiers; (9) if participants were infants, children, or adolescents; or (10) if participants were pregnant, postpartum, nursing, had recent surgery, or were undergoing rehabilitation exercise. If multiple articles were published based on the same trial, data were retrieved as 1 independent trial. If there were duplicate results from the same trial, the most updated and comprehensive ones were extracted.

Data Extraction and Quality Assessment
--------------------------------------

In total, 6135 articles were retrieved from the literature search. We excluded 5796 articles after abstract review and 170 after full-text examination. Data extraction was conducted independently by 2 investigators (X.L., X.Z.), and discrepancies were resolved through consensus. The following information was extracted from all eligible studies: general information (first author's name, article title, and country of origin), study characteristics (study design, eligibility criteria, randomization, blinding, cointervention, dropout rate, and reason for dropping out), participant characteristics (age, sex, ethnicity, body mass index, life style, health status, and number of participants in each group), intervention and setting (exercise type, duration, intensity, and supervision), and outcome measures (definition of outcomes, statistical techniques, pre- and postintervention means, standard deviation, sample size of each arm, and adverse events). Maximal oxygen uptake VO~2max~ was measured directly and determined based on the highest VO~2~ obtained prior to volitional fatigue. In this meta-analysis, we focused on biomarkers in blood samples, including plasma, serum, and whole blood. All samples for fasting glucose and insulin measurement in the studies were collected after \>10 hours of fasting.

Data Synthesis and Analysis
---------------------------

Methodological quality was assessed by 2 investigators (X.L., X.Z.) using the Cochrane Collaboration's tool for assessing risk of bias.[@b29] This included random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and other sources of bias. For each trial, the risk of bias was reported as *low risk, unclear risk*, or *high risk*. Disagreement was resolved by discussion. All eligible comparisons from each trial were extracted separately according to exercise intensity. The criteria for classifying exercise interventions as *moderate exercise* or *vigorous exercise* are summarized in Table[2](#tbl2){ref-type="table"}. If the intensity measures were not reported in individual studies, maximum heart rate, maximum heart rate percentage, speed of running, metabolic equivalent, oxygen uptake, or relative metabolic rate were used to classify exercise intensity. To maintain independence, the most vigorous intervention and the control group in each trial were included in the primary analysis if multiple training groups of different intensities were compared with a single control group. Sensitivity analyses were performed by conducting separate analyses of all eligible comparisons for moderate and vigorous exercise interventions, respectively.

###### 

Criteria Used for Exercise Intensity Classification

                                  Moderate     Vigorous
  ------------------------------- ------------ -----------
  Maximum heart rate, beats/min   \<140        ≥140
  Maximum heart rate, %           \<75         ≥75
  Speed of running, m/s           \<6.8        ≥6.8
  Metabolic equivalents           Women: \<6   Women: ≥6
  Men: \<8                        Men: ≥8      
  Oxygen uptake (% of VO~2max~)   \<70         ≥70
  Relative metabolic rate         \<8          ≥8

Mean levels and standard deviations of CRF and CVD biomarkers after the exercise interventions from individual trials were used to calculate weighted mean differences (WMDs) and 95% CIs using DerSimonian and Laird random-effects models.[@b30] Between-study heterogeneity was examined using Q statistics and I^2^ statistics.[@b31],[@b32] I^2^ ≈25%, 50%, and 75% is suggestive, respectively, of low, medium, and high heterogeneity. Egger's tests were used to formally test publication bias.[@b33] If there was any evidence of publication bias, the trim and fill method was used to evaluate the impact of publication bias.[@b34]

All eligible trials were analyzed in subgroup analyses conducted within the strata of the predetermined potential modifiers, including age (mean or median \<50 versus ≥50 years), sex (women versus men), body mass index (obese versus nonobese), lifestyle (active versus sedentary), health status (having at least 1 of the following comorbidities: type 2 diabetes, hypertension, hyperlipidemia, and metabolic syndrome versus none), and trial duration (≥16 versus \<16 weeks). Obesity was defined as body mass index ≥30 kg/m^2^. Active lifestyle was defined according to the report of individual trials. Health status was confirmed by clinical diagnosis or reported medication use. Metaregressions were performed to evaluate the overall impact of potential modifiers.

Two-sided *P*≤0.05 was used as the significance level except for the Q statistic and the Egger's tests (*P*=0.10).[@b35] All statistical analyses were performed with Stata statistical software version 12 (Stata Corp).

Results
=======

Figure[1](#fig01){ref-type="fig"} shows the number of trials included in the analysis for each outcome. A total of 7487 participants aged between 18 and 90 years, from 169 articles based on 160 RCTs, were included in the meta-analysis. Characteristics of eligible studies are summarized in Table[3](#tbl3){ref-type="table"}. Among all participants, 4276 (57.1%) were women; 3211 (42.9%) were men; 5845 (78.1%) were free of type 2 diabetes, hypertension, hyperlipidemia, or metabolic syndrome; and 1640 (21.9%) had at least 1 of those conditions. The median duration of trials was 12 weeks (range: 2 weeks to 2 years).

###### 

Characteristics of the Trials Included in the Meta-Analysis

  Study                                          Age, y                            Sex                      BMI, kg/m^2^                                                          Duration, wk   Activity/Medical Condition       Exercise Type, Intensity and Cointerventions                                                                                   N~T~/N~C~   Marker
  ---------------------------------------------- --------------------------------- ------------------------ --------------------------------------------------------------------- -------------- -------------------------------- ------------------------------------------------------------------------------------------------------------------------------ ----------- ----------------------------------------------------------------------------------------------
  Abderrahman, 2013[@b36]                        Mean: 20.6                        Male only                Mean: 22.8                                                            7              NR/Health                        Running/Vigorous/No                                                                                                            9/6         Absolute CRF, Relative CRF
  Ahmaidi, 1998[@b37]                            53 to 74                          NR                       NR                                                                    12             Sedentary/Health                 Walking/Jogging/Vigorous/No                                                                                                    11/11       Absolute CRF, Relative CRF
  Aldred, 1995[@b38]                             41 to 55                          Female only              T: 24.8±1.0 C: 26.8±0.8                                               12             Sedentary/Health                 Walking/Moderate/No                                                                                                            11/11       TC, HDL-C2 LDL-C, FFA
  Ashutosh, 1997[@b39]                           20 to 60                          Female only              Overweight or obesity                                                 46             NR/Health                        Aerobic exercise/NR/Dietary intervention                                                                                       9/6         Absolute CRF, Relative CRF
  Asikainen, 2002[@b40]                          48 to 63                          Female only              Mean: 26.2                                                            24             Sedentary/Health                 Walking/Vigorous/No                                                                                                            20/38       Relative CRF
  Baker, 1986[@b41]                              Mean: 58.2                        Male only                NR                                                                    20             Sedentary/Health                 Aerobic training/Vigorous/No                                                                                                   20/14       Absolute CRF, Relative CRF, TC, HDL-C, LDL-C, VLDL-C
  Balducci, 2010, 2012[@b42]                     C: 58.8±8.6 T: 58.8±8.5           NR                       C: 31.9±4.6 T: 31.2±4.6                                               52             Sedentary/Diabetes mellitus      Aerobic and resistance training/Moderate/No                                                                                    288/275     Relative CRF, TC, TG, HDL-C, LDL-C, CRP, Fasting glucose, Insulin, HOMA-IR HbA1c
  Beavers, 2010[@b43]                            60 to 79                          Female: 67%              \>28.0                                                                78             Active/Health                    Walking and interactive, health education in control                                                                           97/93       Leptin
  Bell, 2010[@b44]                               Male: 49±11 Female: 50±9          NR                       Mean: 30                                                              24             Sedentary/Health                 Walking/Moderate/No                                                                                                            43/45       Absolute CRF, Relative CRF, TC, TG, HDL-C, LDL-C, Fasting glucose
  Bermon, 1999[@b45]                             67 to 80                          Male: 16                 T: 24.9±0.5 C: 25.9±0.6                                               8              Sedentary/Health                 Strength training/Vigorous/No                                                                                                  16/16       IGF-1, IGF-BP
  Biddle, 2011[@b46]                             Mean: 34.8±12.6                   Female 13                Mean: 36.3±6.7                                                        4              Sedentary/Health                 Small-sided games-based exercise/NR/No                                                                                         9/7         Absolute CRF, Relative CRF, TC, TG, HDL-C, LDL-C, CRP, Fasting glucose, HbA1c
  Blumenthal, 1991[@b47]                         60 to 83                          Female: 50%              NR                                                                    60             Sedentary/Health                 Aerobic exercise or yoga/Vigorous/No                                                                                           15/15       Absolute CRF, Relative CRF
  Blumenthal, 1991[@b48]                         29 to 59                          Male: 62%                Mean: 26.9                                                            16             NR/untreated mild hypertension   Aerobic exercise training/Joging                                                                                               39/22       Absolute CRF, Relative CRF
  Boardley, 2007[@b49]                           ≥65                               Male: 27%                NR                                                                    16             Sedentary/Health                 Resistance training and aerobic walking/Moderate/No                                                                            33/35       TC, TG, HDL-C, LDL-C
  Bobeuf, 2011[@b50]                             59 to 73                          Female: 52.6%            Mean: 26.2±2.6                                                        24             Sedentary/Health                 Resistance training/Vigorous/Vitamins C/E supplementation                                                                      17/12       TC, TG, HDL-C, LDL-C
  Boreham, 2000[@b51]                            18 to 22                          Female only              NR                                                                    7              Sedentary/Health                 Stair climbing/Moderate/No                                                                                                     12/10       TC, HDL-C
  Boudou, 2003[@b52]                             Mean: 45.4±7.2                    Male only                Mean: 29.6±4.6                                                        8              NR/Diabetes mellitus             Endurance exercise/Vigorous/No                                                                                                 8/8         Adiponectin, Leptin, Insulin
  Bourque, 1997[@b53]                            23 to 43                          Female only              Mean: 23.1±4.9                                                        12             Sedentary/Health                 Endurance exercise/Vigorous/No                                                                                                 6/7         Relative CRF
  Braith, 1994[@b54]                             60 to 79                          Female: 54.5%            NR                                                                    24             Sedentary/Health                 Walking/Vigorous/No                                                                                                            14/11       Relative CRF
  Broeder, 1992[@b55]                            18 to 35                          Male only                Mean: 25.3                                                            12             NR/Health                        Walk or jog/Vigorous/No                                                                                                        15/19       Relative CRF
  Broman, 2006[@b56]                             69±4                              Female only              NR                                                                    8              NR/Health                        In deep water running/Walking/Vigorous/No                                                                                      15/9        Absolute CRF, Relative CRF
  Burr, 2011[@b57]                               Mean: 26                          NR                       NR                                                                    6              Sedentary/Health                 Vehicle riding/Vigorous/No                                                                                                     34/12       Relative CRF, Fasting glucose
  Camargo, 2008[@b58]                            Mean: 29                          Male only                Mean: 27.3                                                            12             Sedentary/Health                 Aerobic training/Moderate/No                                                                                                   7/7         Relative CRF
  Campbell, 2007[@b59]                           40 to 75                          Female only              29.9 to 28.7                                                          52             Sedentary/Health                 Aerobic Exercise/Moderate/No                                                                                                   17/15       Absolute CRF, Relative CRF, CRP
  Canuto, 2012[@b60]                             18 to 64                          Female only              Mean: 34.8                                                            12             NR/Health                        Resistance training/Moderate/Education                                                                                         29/30       TC, TG, HDL-C, LDL-C, CRP, Fasting glucose, Insulin, HbA1c
  Carroll, 2012[@b61]                            T: 39.3±7.8 C: 41.0±7.7           Female only              T: 39.9±7.4 C: 41.0±7.7                                               12             Sedentary/Health                 Treadmill walking/Moderate/Lifestyle intervention                                                                              22/22       Absolute CRF, Relative CRF
  Chan, 2013[@b62]                               Mean: 54±11                       Female only              Mean: 31±7                                                            10             Sedentary/Hypertension           Treadmill walking/Vigorous/Education                                                                                           10/13       Relative CRF,
  Chandler, 1996[@b63]                           60 to 79                          Female: 38.6%            NR                                                                    24             NR/Health                        Endurance training/Moderate/No                                                                                                 16/11       Relative CRF, PAI-1
  Cho, 2011[@b64]                                34 to 60                          Female only              Mean: 25.6                                                            12             Sedentary/Health                 Walking/Moderate/No                                                                                                            13/10       Relative CRF,TG, HDL-C FFA, Fasting glucose, Insulin, HOMA-IR
  Christiansen, 2010[@b65]                       18 to 45                          Female: 38               30 to 40                                                              12             Sedentary/Health                 Aerobic exercise/Vigorous/Dietary intervention                                                                                 21/19       Absolute CRF,TC, TG, HDL-C, FFA, IL-6, IL-18, Adiponectin, Fasting glucose, Insulin, HOMA-IR
  Church, 2007[@b66]                             45 to 75                          Female only              25 to 43                                                              24             Sedentary/Health                 Aerobic exercise/Moderate/No                                                                                                   103/102     Absolute CRF, relative CRF, TG, HDL-C, LDL-C, Fasting glucose
  Ciolac, 2011[@b67]                             20 to 30                          Female only              Mean: 23.78                                                           16             Sedentary/Health                 Endurance exercise/Vigorous/No                                                                                                 11/12       Relative CRF,TC, TG, HDL-C, LDL-C, Fasting glucose, Insulin, HOMA-IR
  Coker, 2009[@b68]                              65 to 90                          Female: 50%              26 to 37                                                              12             NR/Health                        Cycle ergometer/Moderate/No                                                                                                    6/6         Absolute CRF
  Cortez-Cooper, 2008[@b69]                      40 to 80                          Female: 73.8%            \<30                                                                  13             Sedentary/Health                 Aerobic exercise strength training vs stretching/Moderate/No                                                                   12/12       Relative CRF,TC, TG, HDL-C, LDL-C, Endothelin-1, Fasting glucose
  Cox, 1993[@b70]                                20 to 45                          Male only                Mean: 26.3 (25.7 to 26.9)                                             4              Sedentary/Health                 Not report/Vigorous/Drink low-alcohol beer or continue their normal drinking habits                                            19/16       TC, TG, HDL-C, HDL-C2, HDL-C3, LDL-C, Apo AI, Apo AII, Apo B
  Cox, 2003[@b71]                                Mean: 42.4±5.0                    Male only                Overweight or obesity                                                 16             Sedentary/Hypertension           NR/Moderate & vigorous/Dietary intervention and usual dietary                                                                  13/17       Absolute CRF
  Dalleck, 2009[@b72]                            45 to 75 year                     Female only              Normal                                                                12             Sedentary/Health                 NR/Moderate/No                                                                                                                 8/10        Absolute CRF, Relative CRF,TC, TG, HDL-C, LDL-C, Fasting glucose
  De Vito, 1999[@b73]                            60 to 70                          Female only              NR                                                                    12             Sedentary/Health                 Walking/Moderate/No                                                                                                            11/9        Absolute CRF, Relative CRF
  Dimeo, 2012[@b74]                              42 to 78                          Female: 58%              Mean: 29.4                                                            12             NR/Hyperlipidemia                Walking on a treadmill/NR/No                                                                                                   22/25       Relative CRF
  Dipietro, 2006[@b75]                           62 to 84                          Female only              Mean: 27.3                                                            36             Sedentary/Health                 Aerobic training/Moderate/No                                                                                                   9/7         Relative CRF,FFA, Fasting glucose, Insulin
  Duncan, 1991[@b76]                             20 to 40                          Female only              NR                                                                    24             Sedentary/Health                 Walk/Moderate/No                                                                                                               12/13       Relative CRF,TC, TG, HDL-C, LDL-C
  Duscha, 2005[@b77]                             40 to 65                          NR                       25 to 35                                                              36             NR/Hyperlipidemia                Walking/Moderate/No                                                                                                            25/37       Absolute CRF, Relative CRF
  Eguchi, 2012[@b78]                             20 to 65                          Female only              Mean: 25.1±3.9                                                        12             NR/Health                        Endurance training using bicycle ergometers/Moderate/No                                                                        8/10        Absolute CRF, Relative CRF,TC, TG, HDL-C, LDL-C, Fasting glucose, HbA1c
  Fatouros, 2005[@b79]                           65 to 78                          Male only                28.7 to 30.2                                                          24             Sedentary/Health                 Resistance exercises/Moderate/No                                                                                               12/10       Relative CRF, Adiponectin, Leptin, Fasting glucose, HOMA-IR
  Finucane, 2010[@b80]                           67.4 to 76.3                      Female: 44%              Mean: 27.2                                                            12             NR/Health                        Cycle ergometer/Moderate/No                                                                                                    48/48       TC, TG, HDL-C, LDL-C, Fasting glucose, HbA1c
  Friedenreich, 2011[@b81]                       50 to 74                          Female only              22 to 40                                                              52             Sedentary/Health                 Aerobic exercise/Vigorous/No                                                                                                   154/154     Adiponectin, Leptin, Fasting glucose, Insulin, HOMA-IR, IGF-1, IGF-BP
  Garber, 1992[@b82]                             24 to 50                          Female: 75%              NR                                                                    8              Sedentary/Health                 Walk-jog/Moderate/No                                                                                                           13/9        Relative CRF
  Geogiades, 2000[@b83]                          ≥29                               Female: 44%              25 to 37                                                              24             Sedentary/Hypertension           Aerobic exercise/Vigorous/No                                                                                                   36/19       Relative CRF
  Gormley, 2008[@b84]                            18 to 31                          Female: 65.5%            Mean: 24.3                                                            6              Sedentary/Health                 Aerobic/Moderate/No                                                                                                            14/13       Relative CRF
  Gram, 2010[@b85]                               25 to 80                          Female: 45.6%            NR                                                                    52             NR/Diabetes mellitus             Strength training and aerobic exercise/Moderate/No                                                                             21/20       Absolute CRF,TC, HDL-C, LDL-C, HbA1c
  Grandjean, 1996[@b86]                          NR                                Female only              NR                                                                    24             Sedentary/Health                 Walking and jog and cycling/Vigorous/No                                                                                        20/17       Absolute CRF,TC, TG, HDL-C, LDL-C, VLDL-C
  Gray, 2009[@b87]                               18 to 65                          Female: 77%              Mean: 28.6                                                            12             Sedentary/Health                 Pedometer-based walking/Moderate/No                                                                                            24/24       CRP, IL-6, TNF-α, Fasting glucose, Insulin, HOMA-IR
  Guadalupe-Grau, 2009[@b88]                     Mean: 23.9±2.4                    Female: 34.8%            C: 24.0±3.6 T: 22.8±2.0                                               9              Active/Health                    Strength combined with plyometric jumps training/Vigorous/No                                                                   8/15        Leptin
  Hagan, 1986[@b89]                              Mean: 36.6                        Female: 50%              Normal                                                                12             Sedentary/Health                 Aerobic training/Moderate/Dietary training                                                                                     12/12       Absolute CRF, Relative CRF,TC, TG, HDL-C, LDL-C, VLDL-C
  Hass, 2001[@b90]                               35 to 55                          Female: 50%              NR                                                                    12             Sedentary/Health                 NR/Moderate/No                                                                                                                 17/9        Absolute CRF, Relative CRF
  Hendrickson, 2010[@b91]                        18 to 26                          Female only              NR                                                                    12             Active/Health                    Aerobic endurance and strength training/Vigorous/No                                                                            13/10       Relative CRF
  Heydari, 2013[@b92]                            Mean: 24.9±4.3                    Male only                Mean: 28.7±3.1                                                        12             Sedentary/Health                 High-intensity intermittent exercise/Vigorous/No                                                                               20/18       Absolute CRF, Relative CRF
  Heydari, 2013[@b92]                            Mean: 24.9±4.3                    Male only                Mean: 28.7                                                            12             Active/Health                    High-intensity intermittent exercise/Vigorous/No                                                                               25/21       Absolute CRF, Relative CRF
  Hilberg, 2013[@b93]                            T: 49±6 C: 48±6                   Male only                NR                                                                    12             NR/Health                        NR/Vigorous/No                                                                                                                 22/22       Relative CRF
  Hiruntrakul, 2010[@b94]                        18 to 25                          Male only                C: 21.35±3.54 T: 20.99±3.35                                           12             Sedentary/Health                 Aerobic exercise/Moderate/No                                                                                                   19/18       Relative CRF, HDL-C
  Ho, 2012[@b95]                                 40 to 66                          Female: 83.5%            25 to 40                                                              12             Sedentary/Health                 Aerobic resistance training/Moderate/No                                                                                        15/16       Relative CRF, TC, TG, HDL-C, LDL-C, Fasting glucose, Insulin
  Hu, 2009[@b96]                                 20 to 45                          Male only                NR                                                                    10             Sedentary/Health                 Progressive strength training/Moderate/No                                                                                      48/21       Absolute CRF, Relative CRF,
  Huttunen, 1979[@b97]                           40 to 45                          Male only                NR                                                                    16             Sedentary/Health                 Walking, Jogging, Swimming, Skiing, or Cycling/Moderate/No                                                                     44/46       Relative CRF, HDL-C, Apo AI, Apo AII
  Tsuji, 2000[@b98]                              60 to 81                          Female: 53%              NR                                                                    25             Active/Health                    Endurance session with a bicycle ergometer, and a resistance exercise training session using rubber films/Moderate/Education   31/33       Relative CRF
  Irwin, 2012[@b99]                              59 to 86                          Female: 61%              NR                                                                    9              Sedentary/Health                 Tai Chi Chih vs health education/Moderate/No                                                                                   46/37       CRP, IL-6, IL-18
  Larose, 2011[@b100]                            39 to 70                          Female 36.2%             Mean: 34.9                                                            24             Sedentary/Diabetes mellitus      Aerobic or resistance training/Vigorous/No                                                                                     60/63       Relative CRF, HbA1c
  Jessup, 1998[@b101]                            61 to 77                          Female: 52%              NR                                                                    16             Sedentary/Health                 Treadmills and stair-climbers/Vigorous/No                                                                                      11/10       Relative CRF
  Kadoglou, 2012[@b102]                          Mean: 61.3±2.1                    Female: 67.6%            T: 32.74±4.05 C: 31.58±5.71                                           12             NR/Diabetes mellitus             Resistance Exercise/Vigorous/No                                                                                                23/24       Relative CRF, TC, TG, HDL-C, LDL-C, Fasting glucose, Insulin, HOMA-IR, HbA1c, Fibrinogen
  Karstoft, 2013[@b103]                          C: 57.1±3.0 T: 60.8±2.2           Female: 31%              NR                                                                    16             NR/Diabetes mellitus             Walking/Moderate/No                                                                                                            12/8        Absolute CRF, Relative CRF,TC, TG, HDL-C, LDL-C, Fasting glucose, Insulin, HbA1c
  King, 1989[@b104]                              Male 49±6 Female 47±5             Female: 50%              NR                                                                    24             Sedentary/Health                 Aerobic/Exercise/Training/Moderate/No                                                                                          29/28       Relative CRF
  Kirk, 2003[@b105]                              19 to 30                          Male only                27 to 32                                                              36             Sedentary/Health                 Aerobic exercise/Moderate/No                                                                                                   16/15       Absolute CRF, Relative CRF
  Kirk, 2003[@b105]                              19 to 30                          Female only              27 to 32                                                              36             Sedentary/Health                 Aerobic Exercise/Moderate/No                                                                                                   25/18       Absolute CRF, Relative CRF
  Kiviniemi, 2007[@b106]                         T: 31±6 C 35±8                    Male only                T: 24±2 C: 25±1                                                       4              Active/Health                    Running/Vigorous/No                                                                                                            9/10        Absolute CRF, Relative CRF
  Kokkinos, 1998[@b107]                          35 to 76                          Male only                T: 30±4 C: 31±5                                                       16             Sedentary/Hypertension           Aerobic/Exercise/Moderate/No                                                                                                   15/19       TC, TG, HDL-C, HDL-C2, HDL-C3, LDL-C, Apo AI, Apo B
  Kraemer, 1997,[@b108] 1999[@b109]              Mean: 35.4±8.5                    Female only              C: 28.2±4.0 T: 28.3±4.2                                               12             NR/Health                        Aerobic endurance exercise/Vigorous/Dietary intervention                                                                       9/8         Absolute CRF, Relative CRF, TG, Fasting glucose
  Krogh, 2012[@b110]                             18 to 60                          Female: 67%              NR                                                                    12             NR/Health                        Aerobic exercise/Vigorous/No                                                                                                   56/59       Relative CRF, TC, TG, HDL-C, Fasting glucose, Insulin
  Krustrup, 2009[@b111]                          20 to 43                          Male only                Mean: 25.7                                                            12             Sedentary/Health                 Recreational soccer/Vigorous/No                                                                                                12/10       Relative CRF, TC, HDL-C, LDL-C,Absolute CRF, CRP, Fasting glucose, Insulin
  Kukkonen-Harjula, 1998[@b112]                  31 to 52                          Female: 53%              18.5 to 32.7                                                          15             Sedentary/Health                 Walking/Training/Moderate/No                                                                                                   58/58       Absolute CRF, Relative CRF, Fibrinogen
  Kurban, 2011[@b113]                            T: 53.77±8.2 C: 53.57±6.6         Female: 51.7%            T: 30.90±4.64 C: 30.23±4.74                                           12             Sedentary/Diabetes Mellitus      Walking/Moderate/No                                                                                                            30/30       Fasting glucose, HbA1c
  Laaksonen, 2000[@b114]                         20 to 40                          Male only                Mean: 24.4                                                            16             Active/Diabetes mellitus         Sustained running/Moderate/No                                                                                                  20/22       Relative CRF, TC, TG, HDL-C, LDL-C, Apo AI, Apo B, HbA1c
  Labrunee, 2012[@b115]                          Mean: 52.7±8.2                    Female: 82.6%            Mean: 38.5±7.6                                                        12             NR/Diabetes mellitus             Cyclergometer training/NR/No                                                                                                   11/12       Relative CRF, TC, TG, HDL-C, LDL-C, Fasting glucose, HOMA-IR, HbA1c
  Lake, 1996[@b116]                              18 to 28                          Male only                NR                                                                    6              Active/Health                    Running training/Moderate/No                                                                                                   8/7         Relative CRF
  LaPerriere, 1994[@b117]                        18 to 40                          Male only                NR                                                                    10             Sedentary/Health                 Aerobic exercise/Vigorous/No                                                                                                   7/7         Relative CRF
  Lee, 2003[@b118]                               18 to 30                          Male only                NR                                                                    2              Sedentary/Health                 Cycle ergometer/Vigorous/No                                                                                                    12/12       Relative CRF
  Lee, 2012[@b119]                               30 to 50                          Female only              ≥25                                                                   14             NR/Health                        NR/Moderate/No                                                                                                                 8/7         Relative CRF, TC, TG, HDL-C, LDL-C, CRP, IL-6, TNF-α
  LeMura, 2000[@b120]                            Mean: 20.4±1                      Female only              T: 20.8±2.1 C: 21.8±2.3                                               16             Sedentary/Health                 Resistance training and aerobic training/Vigorous/No                                                                           10/12       Relative CRF,TC, TG, HDL-C, LDL-C
  Libardi, 2012[@b121]                           T 48.6+5.0 C 49.1+5.5             Male only                T: 27.5+4.1 C: 24.7+3.3                                               24             Sedentary/Health                 Resistance training/Moderate/No                                                                                                12/13       Relative CRF, TC, TG, HDL-C, LDL-C, CRP, IL-6, TNF-α, Fasting glucose
  de Lima, 2012[@b122]                           20 to 35                          Female only              C: 23.0±2.4 T: 22.8±3.6                                               12             Sedentary/Health                 Muscular endurance/Moderate/No                                                                                                 10/8        Relative CRF
  Lovell, 2011[@b123]                            70 to 80                          Male only                NR                                                                    20             Active/Health                    Cycle ergometer and stretching/Vigorous/No                                                                                     12/12       Absolute CRF, Relative CRF
  Martin, 1990[@b124]                            T: 58.6±4.6 C 60.6±7.4            Female only              NR                                                                    12             Sedentary/Health                 Cycle ergometer training/Vigorous/No                                                                                           14/14       Absolute CRF, Relative CRF
  McAuley, 2002[@b125]                           25 to 70                          Female: 67%              \<27                                                                  16             NR/Health                        NR/Moderate/Dietary intervention                                                                                               29/23       TC, TG, HDL-C, LDL-C, Fasting glucose, Insulin
  Meckling, 2007[@b126]                          20 to 62                          Female only              25 to 30                                                              12             NR/Health                        Resistance training and endurance training/Moderate and vigorous/Dietary intervention or high protein                          11/8        TC, TG, HDL-C, Fasting glucose, Insulin
  Meyer, 2006[@b127]                             30 to 60                          Female: 47%              NR                                                                    12             Sedentary/Health                 Walking or running/Vigorous/No                                                                                                 12/13       Relative CRF
  Miyaki, 2012[@b128]                            Mean: 60±6                        Female only              NR                                                                    8              Sedentary/Health                 Walking and cycling/Moderate/No                                                                                                11/11       Relative CRF, TC, TG, HDL-C, LDL-C, Fasting glucose
  Morey, 2012[@b129]                             60 to 89                          Female: 3%               25 to 45 kg/m^2^                                                      52             NR/Health                        Enhanced fitness intervention/NR/No                                                                                            180/122     TC, TG, HDL-C, LDL-C, Fasting glucose, Insulin, HOMA-IR HbA1c
  Morgan, 2010[@b130]                            50 to 70                          Females: 73.3%           NR                                                                    15             Sedentary/Health                 Walk/Moderate/No                                                                                                               14/15       TC, HDL-C
  Morton, 2010[@b131]                            T: 61+10 C: 63+9                  Females: 22.2%           T: 32+7 C: 30.9+7.0                                                   7              Sedentary/Diabetes mellitus      Walking/Vigorous/No                                                                                                            15/12       Absolute CRF, Relative CRF, Fasting glucose, HbA1c
  Murphy, 2006[@b132]                            Mean: 41.5±9.3                    Female: 64.9%            T: 26.8±5.6 C: 24.4±3.6                                               8              Sedentary/Health                 Walking/Moderate/No                                                                                                            21/12       TC, TG, HDL-C, LDL-C, CRP
  Murtagh, 2005[@b133]                           Mean: 45.7±9.4                    Female: 64.6%            \<30                                                                  12             Sedentary/Health                 Walking/Vigorous/No                                                                                                            18/11       Relative CRF, TC, TG, HDL-C, LDL-C
  Musa, 2009[@b134]                              21 to 36                          Male only                Normal                                                                8              Sedentary/Health                 Interval running/Moderate/No                                                                                                   20/16       TC, HDL-C
  Nemoto, 2007[@b135]                            Mean: 63±6                        Female: 75.6%            C: 22.8 T moderate: 22.8 vigorous: 22.9                               20             NR/Health                        Walking/Moderate/No                                                                                                            43/37       Absolute CRF
  Nicklas, 2009[@b136]                           50 to 70                          Female only              25 to 40                                                              20             Sedentary/Health                 Calorie restriction and aerobic exercise/Moderate/dietary intervention                                                         36/29       TG, HDL-C, LDL-C, Fasting glucose, Insulin
  Niederseer, 2011[@b137]                        T: 66.6±2.1 C: 67.3±4.4           Female: 47.6%            T: 27.1±3.3 C: 25.4±2.8                                               12             Active/Health                    Skiing/Moderate/No                                                                                                             22/20       Relative CRF, TC, TG, HDL-C, LDL-C, CRP VCAM-1, ICAM-1, Endothelin-1, e_selectin
  Nieman, 1993[@b138]                            67 to 85                          Female only              Mean: 23.7                                                            12             Sedentary/Health                 Walk/Moderate/No                                                                                                               14/16       Relative CRF, TC, TG, HDL-C, LDL-C,
  Nieman, 1998[@b139]                            Mean: 45.6±1.1                    Female only              Mean: 33.1±0.6                                                        12             Active/Health                    Walking/Moderate and vigorous/dietary intervention                                                                             22/26       Absolute CRF, TC, Fasting glucose
  Nordby, 2012[@b140]                            20 to 40                          Male only                25 to 30                                                              12             Sedentary/Health                 Endurance training (cycling, running, cross-training, or rowing)/Moderate/Dietary intervention                                 12/12       Absolute CRF, Relative CRF, Fasting glucose, Insulin, HbA1c
  O'donovan, 2005[@b141]                         30 to 45                          Male only                NR                                                                    24             Sedentary/Health                 NR/Moderate/No                                                                                                                 14/15       Absolute CRF, Relative CRF, TC, TG, HDL-C, LDL-C, Fibrinogen
  Panton, 1990[@b142] Pollock, 1991[@b143]       70 to 79                          Female: 53.1%            NR                                                                    24             Sedentary/Health                 Aerobic and resistance training/NR/No                                                                                          13/15       Relative CRF
  Phillips, 2012[@b144]                          62 to 67                          Female only              Overweight or Obesity                                                 12             Active/Health                    Aerobic training/Vigorous/No                                                                                                   11/12       Leptin
  Poehlman, 2000[@b145]                          18 to 35                          Female only              C: 22±2 T: 22±2                                                       24             Sedentary/Health                 Endurance training (N=14), resistance training/Vigorous/No                                                                     14/20       Absolute CRF
  Posner, 1992[@b146]                            60 to 86                          Female: 61.9%            NR                                                                    16             Sedentary/Health                 Cycle ergometer/Moderate/No                                                                                                    166/81      Absolute CRF, Relative CRF
  Probart, 1991[@b147]                           ≥70                               Female only              Mean: 24.6                                                            26             NR/Health                        Walking on a treadmill/Vigorous/No                                                                                             10/6        Absolute CRF, Relative CRF
  Pyka, 1994[@b148]                              64 to 78                          Female: 60%              NR                                                                    104            NR/Health                        Resistance exercise (walking and stretching)/Moderate/No                                                                       8/6         IGF-1
  Chow, 1987[@b149]                              50 to 62                          Female only              NR                                                                    52             NR/Health                        Aerobic exercise or aerobic and strengthening exercises/Vigorous/No                                                            17/15       Relative CRF
  Raz, 1988[@b150]                               24 to 26                          Male only                Mean: 22.8                                                            9              Sedentary/Health                 Aerobic exercise/Vigorous/No                                                                                                   28/27       Relative CRF, TC, TG, HDL-C, HDL-C2, HDL-C3, LDL-C, HbA1c
  Ready, 1996[@b151]                             ≥50                               Female only              NR                                                                    24             Sedentary/Health                 Walk/Moderate/No                                                                                                               17/18       Absolute CRF, Relative CRF, TC, TG, HDL-C, LDL-C
  Romero-Arenas, 2013[@b152]                     55 to 75                          NR                       Mean: 29.9                                                            12             Active/Health                    Resistance training/Moderate/No                                                                                                16/10       Relative CRF
  Santa-Clara, 2003,[@b153] 2006[@b154]          45 to 70                          Female only              Caucasian-American T: 25±3 C: 27±5 African-American T: 29±7 C: 29±6   24             Sedentary/Health                 Treadmill walking/Jogging, stationary cycling, and rowing/Vigorous/No                                                          17/16       Relative CRF, IGF I
  Santiago, 1995[@b155]                          22 to 40                          Female only              ≥31                                                                   40             Sedentary/Hyperlipidemia         Walking/Vigorous/No                                                                                                            16/11       Relative CRF, TC, TG, HDL-C, LDL-C
  Scanga, 1998[@b156]                            Mean: 38±7                        Female only              C: 35.2±3.9 T: 36.6±4.3                                               8              NR/Health                        Aerobic and resistance training/Moderate/Dietary intervention                                                                  10/12       Absolute CRF, Relative CRF
  Seifert, 2009[@b157]                           C: 30±5 T: 32±6                   Male only                25 to 30                                                              12             Sedentary/Health                 Endurance training/Moderate/Endurance training                                                                                 10/7        Fasting glucose
  Lamina, 2011[@b158]                            50 to 70                          Male only                20 to 30                                                              8              Sedentary/Hypertension           Bicycle ergometer/Vigorous/No                                                                                                  112/105     Relative CRF
  Sillanpaa, 2009,[@b159] 2010[@b160]            39 to 64                          Female only              Normal                                                                21             NR/Health                        NR/Vigorous/                                                                                                                   15/12       TC, TG, HDL-C, LDL-C, Fasting glucose, Insulin
  Sloan, 2013[@b161]                             T: 54.1±5.8 C: 54.1±4.9           Female only              T: 29.2±4.9 C: 27.1±5.9                                               16             Sedentary/Health                 Walking/Moderate/No                                                                                                            16/16       Relative CRF
  Spence, 2013[@b162]                            NR                                Male only                T: 73.0±16.9 C: 81.7±15.23                                            24             Active/Health                    Endurance vs resistance/Moderate/No                                                                                            10/13       Absolute CRF, Relative CRF
  Stachenfeld, 1998[@b163]                       \> 65                             Female only              NR                                                                    24             Active/Health                    Aerobic training/Vigorous/No                                                                                                   9/8         Relative CRF
  Stein, 1992[@b164]                             T: 46.2±6.1 C: 45.0±6.1           Male only                NR                                                                    8              Sedentary/Health                 Aerobic exercise training/Moderate/No                                                                                          19/14       Absolute CRF
  Stensel, 1993[@b165]                           42 to 59                          Male only                Normal                                                                52             Sedentary/Health                 Brisk/Walking/Moderate/No                                                                                                      24/24       TC, TG, HDL-C, LDL-C, VLDL-C, Apo AI, Apo B, Lp-A
  Stensvold, 2010[@b166]                         Mean: 50.2±9.5                    Female: 39.5%            C: 31.9±4.1 T: 32.2±4.2                                               12             Sedentary/Health                 Strength training vs aerobic interval training/Vigorous/No                                                                     11/10       Relative CRF, TC, TG, HDL-C, Fasting glucose, C-peptide, HbA1c
  Strasser, 2009[@b167]                          \>70                              Females: 55.6%           Mean: 26.9                                                            24             Sedentary/Health                 Endurance training or--and resistance training/Vigorous/No                                                                     13/14       Relative CRF
  Sung, 2012[@b168]                              \>70                              Female: 65%              NR                                                                    24             NR/Diabetes mellitus             Walking/Moderate/No                                                                                                            22/18       TC, TG, HDL-C, LDL-C, Fasting glucose, HbA1c
  Takeshima, 2002[@b169]                         60 to 75                          Female only              NR                                                                    7              Sedentary/Health                 Stretching, endurance-type exercise (walking and dancing, 30 min), Resistance exercise/Vigorous/No                             15/15       TC, TG, HDL-C, LDL-C
  Takeshima, 2004[@b170]                         60 to 83                          8 Males and 10 Females   NR                                                                    12             Sedentary/Health                 Progressive accommodating circuit exercise/Vigorous/No                                                                         18/17       Absolute CRF, TC, TG, HDL-C, LDL-C
  Thomas, 1984[@b171]                            18 to 32                          Female only              NR                                                                    12             Active/Health                    Running/Vigorous/No                                                                                                            9/6         Absolute CRF, Relative CRF, TC, TG, HDL-C
  Thompson, 2010[@b172]                          45 to 64                          Male only                C: 28.0±2.7 T: 28.5±2.9                                               24             Sedentary/Health                 NR/Moderate/Dietary intervention                                                                                               20/21       Relative CRF,TC, TG, HDL-C, CRP, IL-6, Fasting glucose, Insulin, HOMA-IR
  Tjonna, 2008[@b173]                            Mean: 52.3±3.7                    Female: 53.6%            C: 32.1±3.3 T: 29.4±4.9                                               16             NR/Health                        Aerobic interval training/Vigorous/No                                                                                          8/9         Relative CRF, TG, HDL-C, Adiponectin, Fasting glucose, Insulin, HOMA-B
  Toledo, 2008[@b174]                            \>30                              Female: 62.5%            T: 34.8±1.1 C: 33.4±1.2                                               16             Sedentary/Health                 Walking/Moderate/Dietary training                                                                                              9/7         FFA, Fasting glucose, Insulin
  Tseng, 2013[@b175]                             18 to 29                          Male only                                                                                      12             NR/Health                        Aerobic, resistance or combined aerobic and resistance training/Moderate/                                                      10/10       TG, HDL-C, Fasting glucose
  Tulppo, 2003[@b176]                            35±10                             Male only                Moderate: 25±3 Vigorous: 25±2 C: 25±3                                 8              Sedentary/Health                 Walking and Jogging/Vigorous/No                                                                                                16/11       Absolute CRF, Relative CRF
  Utter, 1998[@b177]                             25 to 75                          Female only              25 to 65                                                              12             Sedentary/Health                 Walk/Moderate and vigorous/Dietary intervention                                                                                21/22       Absolute CRF, Relative CRF
  Van Aggel-Leijssen, 2001,[@b178] 2001[@b179]   C: 38.6±6.5 T: 39.3±7.7           Male only                C: 32.6±2.5 T: 32.0±2.1                                               12             Sedentary/Health                 Cycling on an ergometer, walking, and aqua-jogging/Moderate/Energy restriction and dietary intervention                        20/17       Absolute CRF, FFA, Fasting glucose, Insulin
  Van Den Berg, 2010[@b180]                      18 to 30                          Male only                NR                                                                    7              Sedentary/Health                 Motor-driven treadmill/Moderate/No                                                                                             9/13        Absolute CRF, Relative CRF
  Vicente-Campos, 2012[@b181]                    62 to 67                          Female: 60%              NR                                                                    28             Sedentary/Health                 Aerobic training/Vigorous/No                                                                                                   22/21       TC, TG, HDL-C, LDL-C
  Vincent, 2002[@b182]                           60 to 83                          Female and Male          NR                                                                    24             Sedentary/Health                 Resistance training/Moderate/No                                                                                                24/16       Relative CRF
  Vissers, 2010[@b183]                           C: 44.8±11.4 T: 44.7±13.0         Female: 74.7%            C: 29.8±2.6 T: 33.1±3.4                                               52             Active/Health                    Bicycle ergometer/Vigorous/No                                                                                                  20/20       TG, HDL-C
  Vitiello, 1997[@b184]                          Male: 66.9±1.0 Female: 67.1±1.7   Female: 40.3%            NR                                                                    24             Sedentary/Health                 Endurance or stretching/Flexibility/Moderate/No                                                                                30/22       Relative CRF, IGF-1
  Volpe, 2008[@b185]                             Mean: 44.2±7.2                    Female only              Mean: 30.5±2.7                                                        52             Sedentary/Health                 Skiing/NR/Dietary intervention                                                                                                 14/14       TC, TG, HDL-C, LDL-C
  Waib, 2011[@b186]                              47 to 56                          Training: 60.8%          T: 30.0 (28.8 to 31.2) C: 29.6 (27.8 to 31.5)                         15             Sedentary/Hypertension           Aerobic training jogging on an electronic treadmill/Moderate/No                                                                55/24       Relative CRF, HOMA-IR, C-peptide
  Wallman, 2009[@b187]                           18 to 64                          Female: 75%              Mean: 30±2                                                            8              Sedentary/Health                 Aerobic Exercise/Vigorous/Dietary education                                                                                    6/8         TC, TG, HDL-C, LDL-C
  Wang, 2005[@b188]                              C: 24.7±2.3 T: 23.5±1.6           Male only                C: 22.7±1.7 T: 23.1±0.6                                               8              Sedentary/Health                 Bicycle ergometer/Moderate/No                                                                                                  15/15       Relative CRF
  Wang, 2011[@b189]                              T: 21.5±0.7 C: 22.9±0.4           Male only                T: 22.9±0.4 C: 23.3±0.7                                               4              Sedentary/Health                 Bicycle ergometer/Moderate/No                                                                                                  10/10       Relative CRF
  Warner, 1989[@b190]                            27 to 63                          Female: 35.3%            NR                                                                    12             Sedentary/Hyperlipidemia         Aerobic training/Vigorous/Fish oil intervention                                                                                7/7         Relative CRF, LDL-C, Apo B
  Warren, 1993[@b191]                            Mean: 73.6±0.7                    Female only              Normal                                                                12             Sedentary/Health                 Walking or calisthenics control/Moderate/No                                                                                    14/16       Relative CRF
  Watkins, 2003[@b192]                           NR                                NR                       T: 33.4±4.5 C: 34.0±5.2                                               24             Sedentary/Health                 Aerobic training/Vigorous/Weight lost                                                                                          14/9        Relative CRF,TC, TG, HDL-C, LDL-C, Fasting glucose, Insulin
  Wong, 1990[@b193]                              Mean: 62.7±3.1                    Male only                Normal                                                                52             NR/Health                        Treadmill walking/Moderate/No                                                                                                  69/69       Absolute CRF,
  Woods, 1999[@b194]                             Mean: 65±0.8                      NR                       NR                                                                    24             Sedentary/Health                 Aerobic exercise/Moderate/No                                                                                                   14/15       Absolute CRF, Relative CRF
  Wu, 2011[@b195]                                45 to 64                          Female: 71.9%            16.0 to 33.3                                                          36             NR/Health                        Aerobic exercise, stretching exercise/Vigorous/No                                                                              68/67       TG, Adiponectin, Fasting glucose, Insulin, HOMA-IR
  Yoshizawa, 2009[@b196]                         50 to 65                          Female only              Mean: 23.7                                                            8              Sedentary/Health                 Resistance training/Moderate/No                                                                                                12/13       Relative CRF, TC, TG, HDL-C, LDL-C
  Yoshizawa, 2009[@b197]                         32 to 59                          Female only              T: 24.6±1.1 C: 21.8±1.0                                               12             Sedentary/Health                 Aerobic exercise training/Moderate/No                                                                                          12/12       Relative CRF, TC, HDL-C, LDL-C
  You, 2006[@b198]                               50 to 70                          Female only              25 to 40                                                              20             Sedentary/Health                 Treadmill/Moderate/Dietary intervention                                                                                        13/14       Absolute CRF, Relative CRF
  Ziemann, 2011[@b199]                           T: 21.6±1.1 C: 21.0±0.9           Male only                T: 24.5±1.8 C: 23.0±1.9                                               6              Active/Health                    NR/Vigorous/Physical education                                                                                                 10/11       Absolute CRF, Relative CRF

Apo AI indicates apolipoprotein A1; Apo AII, apolipoprotein A2; Apo B, apolipoprotein B; BMI, body mass index; C, control group; CRF, cardiorespiratory fitness; CRP, C-reactive protein; FFA, free fatty acid; HbA1c, glycosylated hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment--insulin resistance; ICAM-1, intercellular adhesion molecule 1; IGF-1, insulin-like growth factor 1; IGF-BP, insulin-like growth factor binding protein; IL, interleukin; LDL-C, low-density lipoprotein cholesterol; NR, not reported; PAI-1, plasminogen activator inhibitor-1; T, training group; TC, total cholesterol; TNF, tumor necrosis factor; VCAM-1, vascular cell adhesion molecule 1; VLDL-C, very low-density lipoprotein cholesterol.

![Summary of study selection process. In total, 6135 articles were retrieved from the literature search that evaluated the effect of exercise interventions on CRF or cardiometabolic biomarkers. We excluded 5796 articles after abstract review and 170 after full text examination. After exclusion, 160 RCTs reported in 169 articles were included in the meta-analysis. Apo AI indicates apolipoprotein A1; Apo AII, apolipoprotein A2; Apo B, apolipoprotein B; CRF, cardiorespiratory fitness; CRP, C-reactive protein; FFA, free fatty acid; HbA1c, glycosylated hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; HOME-B, homeostatic model assessment-beta cell function; HOMA-IR, homeostatic model assessment--insulin resistance; HOMA-S, homeostatic model assessment-insulin sensitivity; ICAM-1, intercellular adhesion molecule 1; IGF-1, insulin-like growth factor 1; IGF-BP, insulin-like growth factor binding protein; IL, interleukin; LDL-C, low-density lipoprotein cholesterol; Lp(a), lipoprotein(a); PAI-1, plasminogen activator inhibitor-1; RCTs, randomized controlled trials; TC, total cholesterol; TG, triglycerides; TNF-α, tumor necrosis factor α; VCAM-1, vascular cell adhesion molecule 1; VLDL-C, very low-density lipoprotein cholesterol.](jah30004-e002014-f1){#fig01}

Description of Study Quality
----------------------------

The quality of studies included was heterogeneous (Figure[2](#fig02){ref-type="fig"}). Random sequence generation was reported in 50 trials, and allocation concealment was reported in 20 trials; only 1 of these trials showed a high probability of selection bias because the random allocation was not concealed. The risk of potential performance bias was high in all trials because it was not possible to blind participants and trainers in exercise interventions. Among 26 trials reporting the blinding of outcome assessment, the risk of detection bias was high in only 1 trial. The risk of other bias was high in 46 trials because of poor compliance, the use of intention-to-treat analysis, limited sample sizes, or limitations discussed in individual articles.

![Assessment of risk of bias: summary for items of bias.](jah30004-e002014-f2){#fig02}

Cardiorespiratory Fitness
-------------------------

A total of 67 and 123 independent comparisons were included in the primary analysis for absolute and relative CRF, respectively (Table[4](#tbl4){ref-type="table"}). Both measures were significantly raised by exercise interventions (both *P*\<0.001). The WMDs comparing exercise groups and control groups were 0.28 L/min (95% CI 0.23 to 0.33; I^2^=93.7%; *P*\<0.001 for heterogeneity) for absolute CRF and 3.90 mL/kg per minute (95% CI 3.45 to 4.35; I^2^=91.4%; *P*\<0.001 for heterogeneity) for relative CRF. The Egger's tests showed evidence of publication bias in both instances (*P*\<0.05). When applying the trim and fill method, the conclusion regarding the associations between exercise training and CRF did not change (filled analysis for absolute CRF: WMD 0.14 L/min, 95% CI 0.20 to 5.28, *P*\<0.001; filled analysis for relative CRF: WMD 2.56 mL/kg per minute, 95% CI 3.06 to 10.16, *P*\<0.001).

###### 

WMDs in Cardiorespiratory Fitness and Circulating Concentrations of Biomarkers Between Exercise Groups and Control Groups

  Outcome                              No.[\*](#tf4-1){ref-type="table-fn"}   Number of Participants   WMD    95% CI   *P* ~WMD~         
  ------------------------------------ -------------------------------------- ------------------------ ------ -------- ----------------- ---------
  Cardiorespiratory fitness                                                                                                              
   Absolute, L/min                     67                                     1448                     1272   0.28     0.23 to 0.33      \<0.001
   Relative, mL/kg per minute          122                                    2543                     2249   3.94     3.48 to 4.39      \<0.001
  Lipid and lipoprotein markers                                                                                                          
   TC, mg/dL                           68                                     1754                     1604   1.16     −9.28 to 11.99    0.82
   TG, mg/dL                           66                                     1851                     1703   −5.31    −10.63 to −0.89   0.02
   HDL-C, mg/dL                        74                                     1967                     1800   2.32     1.16 to 3.87      \<0.001
   HDL~2~-C, mg/dL                     5                                      91                       92     0.39     −1.93 to 2.32     0.8
   HDL~3~-C, mg/dL                     3                                      62                       62     −0.08    −1.55 to 1.55     0.94
   LDL-C, mg/dL                        59                                     1681                     1525   3.87     −8.12 to 0.39     0.08
   VLDL-C, mg/dL                       7                                      130                      102    −3.09    −8.51 to 2.32     0.29
   Apo AI, g/L                         5                                      63                       62     0.03     0.02 to 0.04      \<0.001
   Apo AII, g/L                        2                                      140                      126    0.01     −0.01 to 0.03     0.2
   Apo B, g/L                          5                                      103                      87     0.01     −0.01 to 0.03     0.4
   FFA, mmol/L                         6                                      70                       62     −0.06    −0.14 to 0.03     0.21
  Adipokine and inflammatory markers                                                                                                     
   CRP, mg/L                           13                                     598                      554    −0.22    −0.78 to 0.34     0.44
   IL-6, pg/mL                         6                                      130                      121    −0.05    −0.27 to 0.17     0.66
   IL-18, pg/mL                        2                                      67                       56     18.3     0.10 to 36.6      0.05
   TNF-α, pg/mL                        3                                      43                       44     0.21     −0.37 to 0.79     0.48
   Adiponectin, μg/mL                  6                                      273                      267    0.52     −0.20 to 1.23     0.16
   Leptin, ng/mL                       7                                      312                      315    −2.72    −4.03 to −1.42    \<0.001
  Glucose/insulin metabolism markers                                                                                                     
   Glucose, mmol/L                     49                                     1720                     1569   −0.07    −0.13 to 0.004    0.06
   Insulin, μIU/mL                     29                                     1272                     1149   −1.03    −1.69 to −0.37    0.002
   HOMA-IR                             14                                     1033                     912    −0.3     −0.49 to −0.11    0.002
   HbA1c, %                            19                                     972                      878    −0.28    −0.42 to −0.14    \<0.001
   C-peptide, nmol/L                   2                                      66                       34     −0.08    −0.29 to 0.46     0.67
   IGF-1, ng/mL                        5                                      230                      207    3.16     −2.98 to 9.31     0.31
   IGF-BP3, μg/mL                      2                                      170                      164    −0.002   −0.23 to 0.23     0.99
  Hemostatic factors                                                                                                                     
   Fibrinogen, g/L                     2                                      36                       39     −0.39    −0.75 to −0.03    0.04
   Endothelin-1, pg/mL                 2                                      34                       32     −0.22    −0.62 to 0.19     0.29
   Angiotensin II, pg/mL               2                                      24                       25     −1.32    −2.11 to −0.54    0.001

Apo AI indicates apolipoprotein A1; Apo AII, apolipoprotein A2; Apo B, apolipoprotein B; CRP, C-reactive protein; FFA, free fatty acid; HbA1c, glycosylated hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment--insulin resistance; IGF-1, insulin-like growth factor 1; IGF-BP3, insulin-like growth factor binding protein 3; IL, interleukin; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; TG, triglycerides; TNF-α, tumor necrosis factor α; VLDL-C, very low-density lipoprotein cholesterol; WMDs, weighted mean differences.

Number of eligible independent comparisons.

Lipid and Lipoprotein Markers
-----------------------------

The number of comparisons for each lipid and lipoprotein marker is shown in Table[4](#tbl4){ref-type="table"}. Exercise training significantly lowered the levels of triglycerides (*P*=0.02) and increased the levels of high-density lipoprotein cholesterol (HDL-C; *P*\<0.001) and apolipoprotein A1 (*P*\<0.001). The WMDs were −5.31 mg/dL (95% CI −10.63 to −0.89; I^2^=71.8%; *P*\<0.001 for heterogeneity) for triglycerides, 2.32 mg/dL (95% CI 1.16 to 3.87; I^2^=87.5%; *P*\<0.001 for heterogeneity) for HDL-C, and 0.03 g/L (95% CI 0.02 to 0.04; I^2^=0.0%; *P*=0.81 for heterogeneity) for apolipoprotein A1. The *P* value of the Egger's test for HDL-C was 0.03, suggesting possible publication bias; however, the results from the trim and fill analysis did not show substantial impact of publication bias on the estimates or the statistics (filled analysis: WMD 2.32 mg/dL, 95% CI 1.16 to 3.87, *P*\<0.001).

Adipokine and Inflammatory Markers
----------------------------------

Significant associations were found for interleukin-18 (WMD 18.3 pg/mL; 95% CI 0.10 to 36.6; I^2^=0.0%; *P*=0.95 for heterogeneity) but not for C-reactive protein, interleukin-6, or tumor necrosis factor α in the primary analysis (Table[4](#tbl4){ref-type="table"}). Although there was no effect on adiponectin, exercise training was significantly associated with reduced levels of leptin (WMD −2.72 ng/mL; 95% CI −4.03 to −1.42; I^2^=82.10%; *P*\<0.001 for heterogeneity) (Table[4](#tbl4){ref-type="table"}).

Markers of Glucose Intolerance and Insulin Resistance
-----------------------------------------------------

Table[4](#tbl4){ref-type="table"} also shows the effects of exercise training on markers of glucose intolerance and insulin resistance. Fasting insulin levels; homeostatic model assessment--insulin resistance, or HOMA-IR; and glycosylated hemoglobin A1c were significantly lowered in exercise groups compared with control groups (*P*=0.002, *P*=0.002, and *P*\<0.001) (Table[4](#tbl4){ref-type="table"}). The WMDs between exercise groups and control groups were −1.03 μIU/mL (95% CI −1.69 to −0.37; I^2^=79.8%; *P*\<0.001 for heterogeneity) for fasting insulin. The WMD for HOMA-IR was −0.30 (95% CI −0.49 to −0.11; I^2^=77.5%; *P*\<0.001 for heterogeneity), whereas the WMD for hemoglobin A1c was −0.28% (95% CI −0.42 to −0.14; I^2^=80.1%; *P*\<0.001 for heterogeneity). The Egger's tests for fasting glucose and insulin were not suggestive of substantial publication bias (*P*=0.18 and *P*=0.24, respectively). The results from the trim and fill analysis suggested that there was no substantial impact of publication bias on the results for HOMA-IR or hemoglobin A1c (filled analysis for HOMA-IR: WMD −0.30, 95% CI −0.49 to −0.11, *P*=0.002; filled analysis for hemoglobin A1c: WMD −0.28%, 95% CI −0.42 to −0.14, *P*\<0.001).

Hemostatic Factors
------------------

The primary analysis examined 3 hemostatic factors: fibrinogen, endothelin-1, and angiotensin II (Table[4](#tbl4){ref-type="table"}). On average, the levels of fibrinogen and angiotensin II were 0.39 g/L (95% CI 0.03 to 0.75; I^2^=45.00%; *P*=0.18 for heterogeneity) and 1.32 pg/mL (95% CI 0.54 to 2.11; I^2^=0.00%; *P*=0.71 for heterogeneity) lower in exercise groups than in control groups. No significant association was found for endothelin-1.

Subgroup Analyses
-----------------

Our metaregression results suggest that the differences in CRF between exercise and control groups were modified by age and sex (absolute CRF: *P*=0.008 and *P*\<0.001 for age and sex, respectively; relative CRF: *P*=0.003 and *P*=0.001 for age and sex, respectively) (Table[5](#tbl5){ref-type="table"}, Figure[3](#fig03){ref-type="fig"}). In addition, the effects of exercise on levels of total cholesterol (*P*=0.04), low-density lipoprotein cholesterol (LDL-C; *P*=0.06), and fasting insulin (*P*=0.05) were modified by the presence of at least 1 of the following comorbidities: type 2 diabetes, hypertension, hyperlipidemia, and metabolic syndrome (Tables[6](#tbl6){ref-type="table"} and [7](#tbl7){ref-type="table"}, Figure[3](#fig03){ref-type="fig"}). Sex differences in the effects of exercise were also found for fasting insulin (*P*=0.04).

###### 

WMDs in Absolute and Relative Cardiorespiratory Fitness Comparing Exercise Intervention Groups to Control Groups by Specific Modifiers

  Modifier                                        Absolute CRF (L/min)   Relative CRF (mL/kg per minute)                                                                     
  ----------------------------------------------- ---------------------- --------------------------------- -------------- ------ --------- ---- ------ -------------- ------ -------
  Age, y                                                                                                                                                                     
   \<50                                           16                     0.47                              0.34 to 0.60   93.4   0.008     28   5.60   4.56 to 6.65   85.1   0.003
   ≥50                                            12                     0.21                              0.11 to 0.32   84.0             30   3.31   2.46 to 4.15   91.0   
  Sex                                                                                                                                                                        
   Women                                          25                     0.19                              0.13 to 0.24   92.3   \<0.001   48   3.24   2.61 to 3.87   88.7   0.001
   Men                                            27                     0.42                              0.32 to 0.53   90.4             37   5.43   4.32 to 6.53   90.2   
  Lifestyle                                                                                                                                                                  
   Active                                         9                      0.33                              0.15 to 0.51   97.0   0.89      14   3.62   1.39 to 5.85   96.5   0.83
   Sedentary                                      43                     0.31                              0.25 to 0.37   88.4             88   3.85   3.36 to 4.33   90.5   
  BMI[†](#tf5-3){ref-type="table-fn"}                                                                                                                                        
   Obese                                          19                     0.28                              0.20 to 0.36   93.3   0.65      19   3.85   2.83 to 4.87   94.9   0.96
   Nonobese                                       20                     0.26                              0.17 to 0.36   89.1             46   4.01   3.22 to 4.79   85.7   
  Health status[‡](#tf5-4){ref-type="table-fn"}                                                                                                                              
   Yes                                            8                      0.33                              0.07 to 0.60   88.2   0.84      16   3.34   2.63 to 4.04   74.8   0.46
   None                                           53                     0.27                              0.22 to 0.33   94.6             94   4.10   3.51 to 4.71   92.7   
  Duration, wk                                                                                                                                                               
   \<16                                           39                     0.33                              0.25 to 0.40   91.3   0.09      69   3.83   3.12 to 4.54   90.7   0.72
   ≥16                                            28                     0.21                              0.15 to 0.28   92.3             54   3.90   3.34 to 4.35   90.4   

BMI indicates body mass index; CRF, cardiorespiratory fitness; WMDs, weighted mean differences,

*P* values for the impact of potential modifiers on the exercise effects.

BMI in kg/m^2^: obese ≥30; nonobese \<30.

Health status: participants having at least 1 of type 2 diabetes, hypertension, hyperlipidemia, or metabolic syndrome (yes) vs those with none of them (none).

###### 

WMDs in Lipid Biomarkers Comparing Exercise Intervention and Control Groups by Specific Modifiers

  Modifier                                        Total Cholesterol (mg/dL)   Total Triglycerides (mg/dL)                                                                       
  ----------------------------------------------- --------------------------- ----------------------------- ---------------- ------ ------ ---- ------- ---------------- ------ ------
  Age, y                                                                                                                                                                        
   \<50                                           12                          −4.25                         −10.1 to 1.55    0.0    0.43   12   −6.20   −14.2 to 2.66    34.3   0.21
   ≥50                                            15                          0.77                          −5.41 to 7.35    72.5          13   1.77    −8.86 to 13.3    75.5   
  Sex                                                                                                                                                                           
   Women                                          28                          1.16                          −5.41 to 7.73    91.6   0.61   27   −1.77   −9.74 to 5.31    76.1   0.25
   Men                                            15                          −0.39                         −5.80 to 5.03    54.3          13   −8.86   −14.2 to −4.43   12.8   
  Lifestyle                                                                                                                                                                     
   Active                                         6                           8.12                          −7.73 to 24.0    92.5   0.71   5    −8.86   −30.1 to 12.4    61.2   0.64
   Sedentary                                      47                          1.93                          −13.9 to 17.4    99.1          43   −3.54   −9.74 to 2.66    75.1   
  BMI[†](#tf6-3){ref-type="table-fn"}                                                                                                                                           
   Obese                                          16                          12.8                          −22.4 to 47.6    99.7   0.20   19   −7.97   −14.2 to −1.77   53.0   0.70
   Nonobese                                       29                          −1.55                         −7.73 to 4.25    83.6          28   −5.31   −14.2 to 4.43    80.7   
  Health status[‡](#tf6-4){ref-type="table-fn"}                                                                                                                                 
   Yes                                            10                          −11.2                         −19.3 to −3.48   75.2   0.04   9    −9.74   −26.6 to 6.20    63.9   0.48
   None                                           47                          −1.55                         −5.41 to 2.32    81.6          44   −4.43   −11.5 to 2.66    75.2   
  Duration, wk                                                                                                                                                                  
   \<16                                           39                          3.87                          −15.5 to 22.8    82.9   0.34   35   −6.20   −13.3 to 0.89    71.1   0.76
   ≥16                                            29                          −3.09                         −7.73 to 1.55    99.2          31   −5.31   −11.5 to 1.77    72.7   

  Modifier                                        HDL-C (mg/dL)   LDL-C (mg/dL)                                                                      
  ----------------------------------------------- --------------- --------------- --------------- ------ ------ ---- ------- ---------------- ------ ------
  Age, y                                                                                                                                             
   \<50                                           16              4.25            2.32 to 6.19    73.9   0.94   9    −3.87   −10.8 to 3.09    49.3   0.38
   ≥50                                            15              3.87            0.77 to 6.96    84.5          14   0.39    −5.03 to 6.19    73.0   
  Sex                                                                                                                                                
   Women                                          28              2.32            0.08 to 4.64    84.8   0.80   24   −1.93   −9.67 to 5.80    95.0   0.93
   Men                                            19              2.71            0.39 to 5.03    92.5          13   −2.32   −8.89 to 4.25    79.7   
  Lifestyle                                                                                                                                          
   Active                                         5               4.25            0.39 to 8.51    86.9   0.52   2    8.12    −10.4 to 27.1    54.9   0.21
   Sedentary                                      52              2.32            0.77 to 3.87    18.6          45   −3.87   −8.12 to 0.39    88.3   
  BMI[‡](#tf6-3){ref-type="table-fn"}                                                                                                                
   Obese                                          19              4.25            1.93 to 6.96    88.1   0.13   14   −0.08   −4.64 to 4.25    62.0   0.33
   Nonobese                                       30              1.16            −1.16 to 3.87   83.0          25   −4.25   −10.4 to 2.32    91.4   
  Health status[‡](#tf6-4){ref-type="table-fn"}                                                                                                      
   Yes                                            11              2.71            −2.32 to 7.73   91.2   0.89   12   −11.6   −19.7 to −3.09   80.8   0.06
   None                                           50              2.32            0.77 to 3.87    87.3          39   −3.09   −7.73 to 1.55    89.3   
  Duration, wk                                                                                                                                       
   \<16                                           39              2.71            1.16 to 4.64    83.0   0.55   29   −3.09   −9.28 to 3.48    89.6   0.63
   ≥16                                            35              1.93            0.15 to 0.28    90.4          30   −4.64   −10.4 to 1.16    92.2   

BMI indicates body mass index; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; WMDs, weighted mean differences.

*P* values for the impact of potential modifiers on the exercise effects.

BMI in kg/m^2^: obese ≥30; nonobese \<30.

Health status: participants having at least 1 of type 2 diabetes, hypertension, hyperlipidemia, or metabolic syndrome (yes) vs those with none of them (none).

###### 

WMDs in Biomarkers of Glucose Intolerance and Insulin Resistance Comparing Exercise Intervention Groups to Control Groups by Specific Modifiers

  Modifier                                        Fasting Glucose (mmol/L)   Fasting Insulin (μIU/mL)                                                                      
  ----------------------------------------------- -------------------------- -------------------------- --------------- ------ ------ ---- ------- ---------------- ------ ------
  Age, y                                                                                                                                                                   
   \<50                                           5                          0.09                       −0.11 to 0.29   91.3   0.57   4    −1.34   −3.44 to 0.76    76.9   0.22
   ≥50                                            7                          0.01                       −0.06 to 0.07   36.9          3    0.45    −1.23 to 2.13    75.6   
  Sex                                                                                                                                                                      
   Women                                          16                         −0.06                      −0.19 to 0.08   91.4   0.93   9    −0.27   −1.12 to 0.57    68.7   0.04
   Men                                            9                          −0.07                      −0.25 to 0.12   84.3          6    −2.86   −3.55 to −2.17   0.0    
  Lifestyle                                                                                                                                                                
   Active                                         2                          −0.20                      −0.74 to 0.34   99.0   0.63   0    NA      NA               NA     NA
   Sedentary                                      29                         −0.06                      −0.16 to 0.03   80.2          17   −0.94   −1.75 to −0.13   78.5   
  BMI[†](#tf7-3){ref-type="table-fn"}                                                                                                                                      
   Obese                                          20                         −0.06                      −0.20 to 0.07   90.7   0.90   13   −0.93   −2.18 to 0.32    82.0   0.88
   Nonobese                                       18                         −0.05                      −0.17 to 0.07   80.7          10   −0.86   −1.52 to −0.19   32.8   
  Health status[‡](#tf7-4){ref-type="table-fn"}                                                                                                                            
   Yes                                            9                          −0.18                      −0.40 to 0.05   0.0    0.40   6    −2.68   −4.67 to −0.70   75.2   0.05
   None                                           27                         −0.03                      −0.11 to 0.06   87.2          14   −0.70   −1.60 to 0.21    77.5   
  Duration, wk                                                                                                                                                             
   \<16                                           30                         −0.10                      −0.22 to 0.03   90.0   0.70   13   −1.35   −2.50 to −0.20   79.3   0.58
   ≥16                                            19                         −0.02                      −0.09 to 0.06   47.5          16   −0.83   −1.83 to 0.17    78.7   

BMI indicates body mass index; NA, not available due to the lack of comparisons reported for active participants; WMDs, weighted mean differences.

*P*-values for the impact of potential modifiers on the exercise effects.

BMI in kg/m^2^: obese ≥30; nonobese \<30.

Health status: participants having at least 1 of type 2 diabetes, hypertension, hyperlipidemia, or metabolic syndrome (yes) vs those with none of them (none).

![Forest plot of effects of exercise interventions on cardiorespiratory fitness, TC, TG, HDL-C, LDL-C, Fasting glucose, and fasting insulin within subgroups. The WMDs (diamonds) and corresponding CIs (extended line) between exercise groups and control groups are shown for each subgroup. Abs. CRF indicates absolute cardiorespiratory fitness; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Rel. CRF, relative cardiorespiratory fitness; TC, total cholesterol; TG, triglycerides; WMDs, weighted mean differences.](jah30004-e002014-f3){#fig03}

After conducting metaregressions, analyses within subgroups were performed. Compared with older people, those aged \<50 years appeared to have larger changes in CRF. Consistent with the metaregression results, men seemed to have greater exercise-related improvement in CRF, LDL-C, and fasting insulin than women did (Figure[3](#fig03){ref-type="fig"}). Exercise interventions appreciably improved the levels of total cholesterol, LDL-C, and fasting insulin (*P*=0.004, *P*=0.01, and *P*=0.01, respectively) in people having at least 1 of type 2 diabetes, hypertension, hyperlipidemia, and metabolic syndrome (Tables[6](#tbl6){ref-type="table"} and [7](#tbl7){ref-type="table"}, Figure[3](#fig03){ref-type="fig"}); no such improvements were observed among people without any of those health conditions (*P*=0.44, *P*=0.19, and *P*=0.13, respectively) (Tables[6](#tbl6){ref-type="table"} and [7](#tbl7){ref-type="table"}, Figure[3](#fig03){ref-type="fig"}).

Sensitivity Analyses
--------------------

In light of the potential impact of exercise intensity, we conducted separate analyses of all eligible comparisons for moderate and vigorous exercise interventions, respectively. The 95% CIs for moderate and vigorous interventions overlapped for both CRF measures and for all biomarkers (Table[8](#tbl8){ref-type="table"}).

###### 

WMDs in Cardiorespiratory Fitness and Circulating Concentrations of Biomarkers Comparing Moderate and Vigorous Exercise Intervention Groups to Control Groups

  Outcome                       Moderate   Vigorous                                   
  ----------------------------- ---------- ---------- ----------------- ---- -------- -----------------
  Cardiorespiratory fitness                                                           
   Absolute, L/min              39         0.22       0.16 to 0.29      33   0.31     0.22 to 0.40
   Relative, mL/kg per minute   64         3.22       2.61 to 4.18      68   3.26     2.63 to 3.89
  Lipids markers                                                                      
   TC, mg/dL                    41         4.25       −7.73 to 16.6     28   3.87     −31.7 to 39.8
   TG, mg/dL                    37         −5.31      −12.4 to 1.77     32   −5.31    −11.5 to 0.09
   HDL-C, mg/dL                 44         1.16       −0.39 to 2.71     33   2.71     0.39 to 5.03
   HDL~2~-C, mg/dL              2          1.16       −0.77 to 3.48     2    1.55     −1.16 to 4.25
   HDL~3~-C, mg/dL              1          −1.16      −5.80 to 3.87     2    0.04     −1.55 to 1.55
   LDL-C, mg/dL                 35         −3.09      −8.12 to 2.32     26   −4.64    −12.0 to 2.32
   VLDL-C, mg/dL                5          −1.93      −5.41 to 1.93     2    −7.35    −22.9 to 6.19
   Apo AI, g/L                  4          0.03       0.02 to 0.04      1    0.00     −0.12 to 0.12
   Apo AII, g/L                 1          −0.001     −0.24 to 0.24     1    0.01     −0.01 to 0.03
   Apo B, g/L                   3          0.01       −0.01 to 0.03     2    −0.02    −0.21 to 0.18
   FFA, mmol/L                  5          −0.06      −0.16 to 0.03     3    −0.04    −0.17 to 0.10
  Inflammatory markers                                                                
   CRP, mg/L                    9          −0.23      −1.01 to 0.55     4    0.04     −0.24 to 0.31
   IL-6, pg/mL                  5          0.02       −0.22 to 0.25     2    −0.39    −0.83 to 0.06
   IL-18, pg/mL                 1          14.0       −128 to 156       1    18.4     0.02 to 36.8
   TNF-α, pg/mL                 3          0.06       −0.48 to 0.60     1    −0.01    −0.93 to 0.91
   Adiponectin, μg/mL           1          3.52       1.17 to 5.87      6    0.52     −0.20 to 1.23
   Leptin, ng/mL                1          −0.70      −1.19 to −0.21    6    −2.56    −4.04 to −1.08
  Insulin resistance markers                                                          
   Glucose, mmol/L              31         −0.04      −0.24 to 0.17     22   0.03     −0.08 to 0.12
   Insulin, μIU/mL              17         −0.91      −2.08 to 0.26     17   −1.32    −2.15 to −0.50
   HOMA-IR                      7          −0.30      −0.66 to 0.06     7    −0.47    −0.82 to −0.12
   HbA1c, %                     11         −0.28      −0.46 to −0.11    7    −2.71    −0.54 to −0.002
   C-peptide, nmol/L            1          0.22       0.19 to 0.25      1    −0.18    −0.62 to 0.26
   IGF-1, ng/mL                 2          −4.64      −29.58 to 20.30   3    3.91     −2.87 to 10.69
   IGF-BP3, μg/mL               0          NA         NA                2    −0.002   −0.23 to 0.23
  Hemostatic factors                                                                  
   Fibrinogen, g/L              0          NA         NA                2    −0.39    −0.75 to −0.03
   Endothelin-1, pg/mL          2          −0.22      −0.62 to 0.19     0    NA       NA
   Angiotensin II, pg/mL        2          −1.32      −2.11 to −0.54    0    NA       NA

Apo AI indicates apolipoprotein A1; Apo AII, apolipoprotein A2; Apo B, apolipoprotein B; CRP, C-reactive protein; FFA, free fatty acid; HbA1c, glycosylated hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment--insulin resistance; IGF-1, insulin-like growth factor 1; IGF-BP3, insulin-like growth factor binding protein 3; IL, interleukin; LDL-C, low-density lipoprotein cholesterol; NA, not available due to the lack of comparisons reported; TC, total cholesterol; TG, triglycerides; TNF-α, tumor necrosis factor α; VLDL-C, very low-density lipoprotein cholesterol; WMDs, weighted mean differences.

Number of eligible independent comparisons.

Discussion
==========

This systematic review and meta-analysis of 160 RCTs involving 7487 participants indicates that exercise training may significantly improve CRF and CVD biomarkers of lipid and lipoprotein metabolism, glucose intolerance and insulin resistance, systemic inflammation, and hemostasis (Figure[4](#fig04){ref-type="fig"}). In addition, we identified several important modifiers, including age, sex, and health status, that may partially modify the exercise effects on cardiovascular health.

![Mechanisms by which exercise training may improve cardiovascular health.](jah30004-e002014-f4){#fig04}

The current meta-analysis shows that exercise, with relatively low risk of side effects compared with medications, may be an effective way to prevent CVD through impact on various biomarkers. Our results from the meta-analysis showed that exercise training significantly raised CRF, which has been demonstrated to be an independent predictor of CVD risk, CVD mortality, and total mortality.[@b200],[@b201] Lower levels of triglycerides and higher levels of HDL-C were observed in exercise groups. Aside from conventional CVD biomarkers, our meta-analysis also examined the effects on biomarkers that have not been well studied in previous studies, including biomarkers of insulin resistance and hemostasis, adipokines, and novel lipid and inflammatory biomarkers. We found evidence supporting the favorable effects of exercise on apolipoprotein A1, interleukin-18, fasting insulin, HOMA-IR, and hemoglobin A1c. Although the exact biological mechanisms are not clear, our findings indicate that exercise may exert cardioprotective effects by altering dyslipidemia, inflammation, insulin resistance, and hemostasis.[@b19]

As a major component of HDL, apolipoprotein A1 plays an important role in the cardioprotective effects of HDL-C.[@b202]--[@b204] Our findings on apolipoprotein A1 strengthen the hypothesis that exercise may accelerate reverse cholesterol transport. Another plausible mechanism by which exercise improves the lipid profile is by regulation of lipoprotein lipase. Various studies have suggested that exercise may decrease the levels of triglycerides and increase the levels of HDL-C through its impact on lipoprotein lipase expression and activity, which were consistent with the results from our meta-analysis.[@b205]--[@b207] In addition, our analysis also confirmed that the proportion of CVD risk that could have been reduced by exercise via effects on total cholesterol and LDL-C is much lower than what has been observed previously.[@b208],[@b209] Consequently, the results from our meta-analysis provide additional evidence in support of the notion that, in addition to modifying total cholesterol and LDL-C, exercise training may also affect cardiovascular health through other pathways. We found that people in exercise groups also had significantly lower levels of IL-18 and several biomarkers of insulin resistance and hemostatic factors, indicating that exercise may exert its effects via pathways of inflammation-characterized atherothrombosis and insulin resistance. A recent review suggested that exercise training may regulate white adipose tissue mass and the expression of adipokines.[@b210] Obesity has become widely regarded as a chronic proinflammatory state, and substantial evidence indicates that chronic inflammation in adipose tissues, especially in white adipose tissue, could lead to insulin resistance.[@b211],[@b212] Consequently, it is biologically plausible that by reducing the white adipose tissue mass and regulating the expression of adipokines, exercise could mitigate the chronic inflammation in adipose tissues, resulting in improved insulin sensitivity. Nevertheless, the exact mechanism remains to be elucidated.

The results from the subgroup analyses also may have important clinical implications. Consistent with previous evidence,[@b213] both moderate and vigorous exercise training appeared to have favorable effects on cardiorespiratory fitness and cardiometabolic health. We found that the differences in CVD risk between exercise groups and control groups were not significantly modified by lifestyle, body mass index, or intervention duration. These findings suggest that exercise interventions may have similar effects on cardiovascular health in populations regardless of these factors. Alternatively, the effectiveness of exercise training appeared to be different across strata of age, sex, and health status. The effects of exercise interventions on CRF measures were modified by age, sex, and health status such that people aged \<50 years, men, and people with type 2 diabetes, hypertension, hyperlipidemia, or metabolic syndrome appeared to benefit more from exercise interventions. We also observed significant modification of the effects on total cholesterol and LDL-C by preexisting medical conditions (type 2 diabetes, hypertension, hyperlipidemia, or metabolic syndromes), and that may explain why we did not find significant effects of exercise on total cholesterol and LDL-C. This finding also suggests that exercise interventions may provide significant benefits for people with those preexisting conditions by lowering total cholesterol and LDL-C.

Strengths of this meta-analysis include the comprehensive and systematic review of both conventional and novel CVD biomarkers, detailed subgroup analyses for potential effect modifiers that have not been conducted previously, assessment of robustness with regard to exercise intensity, and evaluation of the risk of different bias. The 2008 Physical Activity Guidelines Advisory Committee Report included a number of comprehensively systematic reviews and meta-analyses based mostly on observational studies.[@b214] The evidence from RCTs has been relatively scarce, especially for novel cardiometabolic biomarkers. Our study is the first that synthesized evidence from the RCT setting and covered a comprehensive set of both traditional and novel biomarkers. Our findings are corroborated by several previous meta-analyses of RCTs,[@b20],[@b215] but the inclusion of both sexes, more studies, subgroup analyses, and sensitivity analyses allowed us to achieve higher precision in the estimates and to determine the effect modification in subgroups.

This meta-analysis had some limitations. First, the evidence for hemostatic factors is based on a limited number of available trials, and we were not able to synthesize evidence for some novel biomarkers, such as plasminogen activator inhibitor 1, lipoprotein(a), and homocysteine due to sparse available data. Second, subgroup analyses were restricted to outcomes with \>20 studies included, and cutoff points used for categorizing modifiers were arbitrarily selected. Third, due to the heterogeneity of exercise training programs and the limited number of RCTs that provided separate data, this meta-analysis can neither perform a dose-response analysis nor distinguish exercise types. We maximized the utility of data regarding exercise duration and intensity available from original RCTs and found that exercise effects were not significantly different across subgroups defined by duration and intensity. Our findings are consistent with previous evidence showing that both moderate and vigorous exercise training has similarly favorable effects on cardiometabolic health.[@b213] The duration threshold at which exercise exerts its effects needs further investigation. Fourth, to maintain independence, we selected 1 comparison from each trial with exercise groups of different intensities compared with 1 single control group. The results may potentially be subject to bias by excluding several eligible intervention groups with moderate intensity; however, we found that the direction and magnitude of the effects on most of the outcome measures were quite similar between moderate and vigorous interventions (Table[8](#tbl8){ref-type="table"}). Finally, like any meta-analysis, our results may be prone to publication bias and inherent weaknesses of individual studies.

In conclusion, this large meta-analysis of RCTs clearly shows that exercise training significantly improved CRF and some traditional and novel CVD biomarkers in adults without CVD, indicating the causal role of exercise in the primary prevention of CVD morbidity and mortality.
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